Screening for prostate cancer

U.S. preventive services task force recommendation statement

Ned Calonge, Diana B. Petitti, Thomas G. Dewitt, Allen J. Dietrich, Kimberly D. Gregory, Russell Harris, George J. Isham, Michael L. Lefevre, Roseanne Leipzig, Carol Loveland-Cherry, Lucy Nelle Marion, Bernadette Melnyk, Virginia A. Moyer, Judith K. Ockene, George F. Sawaya, Barbara P. Yawn

Research output: Contribution to journalReview article

417 Citations (Scopus)

Abstract

Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer. Methods: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation. Recommendations: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).

Original languageEnglish (US)
Pages (from-to)185-191
Number of pages7
JournalAnnals of internal medicine
Volume149
Issue number3
DOIs
StatePublished - Aug 5 2008

Fingerprint

Advisory Committees
Prostatic Neoplasms
Prostate-Specific Antigen
Early Detection of Cancer
Randomized Controlled Trials
Cross-Sectional Studies
Psychology

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Calonge, N., Petitti, D. B., Dewitt, T. G., Dietrich, A. J., Gregory, K. D., Harris, R., ... Yawn, B. P. (2008). Screening for prostate cancer: U.S. preventive services task force recommendation statement. Annals of internal medicine, 149(3), 185-191. https://doi.org/10.7326/0003-4819-149-3-200808050-00008

Screening for prostate cancer : U.S. preventive services task force recommendation statement. / Calonge, Ned; Petitti, Diana B.; Dewitt, Thomas G.; Dietrich, Allen J.; Gregory, Kimberly D.; Harris, Russell; Isham, George J.; Lefevre, Michael L.; Leipzig, Roseanne; Loveland-Cherry, Carol; Marion, Lucy Nelle; Melnyk, Bernadette; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Yawn, Barbara P.

In: Annals of internal medicine, Vol. 149, No. 3, 05.08.2008, p. 185-191.

Research output: Contribution to journalReview article

Calonge, N, Petitti, DB, Dewitt, TG, Dietrich, AJ, Gregory, KD, Harris, R, Isham, GJ, Lefevre, ML, Leipzig, R, Loveland-Cherry, C, Marion, LN, Melnyk, B, Moyer, VA, Ockene, JK, Sawaya, GF & Yawn, BP 2008, 'Screening for prostate cancer: U.S. preventive services task force recommendation statement', Annals of internal medicine, vol. 149, no. 3, pp. 185-191. https://doi.org/10.7326/0003-4819-149-3-200808050-00008
Calonge, Ned ; Petitti, Diana B. ; Dewitt, Thomas G. ; Dietrich, Allen J. ; Gregory, Kimberly D. ; Harris, Russell ; Isham, George J. ; Lefevre, Michael L. ; Leipzig, Roseanne ; Loveland-Cherry, Carol ; Marion, Lucy Nelle ; Melnyk, Bernadette ; Moyer, Virginia A. ; Ockene, Judith K. ; Sawaya, George F. ; Yawn, Barbara P. / Screening for prostate cancer : U.S. preventive services task force recommendation statement. In: Annals of internal medicine. 2008 ; Vol. 149, No. 3. pp. 185-191.
@article{9ade16338d8e498e90faf4692587ba42,
title = "Screening for prostate cancer: U.S. preventive services task force recommendation statement",
abstract = "Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer. Methods: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation. Recommendations: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).",
author = "Ned Calonge and Petitti, {Diana B.} and Dewitt, {Thomas G.} and Dietrich, {Allen J.} and Gregory, {Kimberly D.} and Russell Harris and Isham, {George J.} and Lefevre, {Michael L.} and Roseanne Leipzig and Carol Loveland-Cherry and Marion, {Lucy Nelle} and Bernadette Melnyk and Moyer, {Virginia A.} and Ockene, {Judith K.} and Sawaya, {George F.} and Yawn, {Barbara P.}",
year = "2008",
month = "8",
day = "5",
doi = "10.7326/0003-4819-149-3-200808050-00008",
language = "English (US)",
volume = "149",
pages = "185--191",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "3",

}

TY - JOUR

T1 - Screening for prostate cancer

T2 - U.S. preventive services task force recommendation statement

AU - Calonge, Ned

AU - Petitti, Diana B.

AU - Dewitt, Thomas G.

AU - Dietrich, Allen J.

AU - Gregory, Kimberly D.

AU - Harris, Russell

AU - Isham, George J.

AU - Lefevre, Michael L.

AU - Leipzig, Roseanne

AU - Loveland-Cherry, Carol

AU - Marion, Lucy Nelle

AU - Melnyk, Bernadette

AU - Moyer, Virginia A.

AU - Ockene, Judith K.

AU - Sawaya, George F.

AU - Yawn, Barbara P.

PY - 2008/8/5

Y1 - 2008/8/5

N2 - Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer. Methods: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation. Recommendations: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).

AB - Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer. Methods: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation. Recommendations: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).

UR - http://www.scopus.com/inward/record.url?scp=49049090790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49049090790&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-149-3-200808050-00008

DO - 10.7326/0003-4819-149-3-200808050-00008

M3 - Review article

VL - 149

SP - 185

EP - 191

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 3

ER -